Lenox Wealth Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$7K Sell
184
-19
-9% -$751 ﹤0.01% 488
2020
Q1
$6K Sell
203
-106
-34% -$3.94K ﹤0.01% 464
2019
Q4
$11K Buy
309
+129
+72% +$4.57K ﹤0.01% 429
2019
Q3
$6K Sell
180
-254
-59% -$9K ﹤0.01% 510
2019
Q2
$17K Sell
434
-33
-7% -$1.31K 0.01% 366
2019
Q1
$19K Buy
467
+417
+834% +$15.5K 0.01% 356
2018
Q4
$5K Buy
+50
New +$2.02K ﹤0.01% 465

Other funds holding FMS

Lenox Wealth Management's FMS Position: Q2 2020 in Review

Lenox Wealth Management reduced its Fresenius Medical Care (FMS) stake by 9.4% in Q2 2020, selling an estimated $751 and leaving 184 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #488.

Lenox Wealth Management first reported a position in FMS in Q4 2018 and has held it in 7 quarters since. The position peaked at $19K in Q1 2019. 179 funds tracked by Wall St. Rank hold FMS as of Q2 2020.

  • Lenox Wealth Management held 184 shares of Fresenius Medical Care worth $7K as of Q2 2020.
  • Lenox Wealth Management sold 19 Fresenius Medical Care shares in Q2 2020, an estimated $751.
  • Fresenius Medical Care made up ﹤0.01% of Lenox Wealth Management's portfolio in Q2 2020, its #488 holding.
  • Lenox Wealth Management first reported a position in Fresenius Medical Care in Q4 2018 and has held it in 7 quarters since.
  • Lenox Wealth Management's Fresenius Medical Care position peaked at $19K in Q1 2019.
  • 179 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.